Although supposed to be under the positive control of mTORC1, several studies have highlighted the role of mTORC2 and AKT in activating lipogenesis through SREBP-1, linking this reactivation to the best metabolic adaptation to hypoxia for tumor cells [41–44]. Here, AKT1 is linked to neoplasm.